Unlocking New Digital Health Technology in Clinical Trials
In the rapidly evolving landscape of digital health technology in clinical trials (DHT), Jeremy Wyatt, CEO of ActiGraph, envisions...
In the rapidly evolving landscape of digital health technology in clinical trials (DHT), Jeremy Wyatt, CEO of ActiGraph, envisions...
The clinical trial industry faces a critical juncture as the dust settles from the COVID-19 pandemic. During the height...
The forefront of personalized medicine is dramatically reshaped by advancements in biomarker discovery and digital health technologies (DHTs) –...
Digital health technologies (DHTs) are revolutionizing the landscape of clinical research, pushing us toward more innovative and patient-centered trial...
The FDA’s latest guidance on Decentralized Clinical Trials (DCTs) marks a pivotal shift in the clinical research landscape. This...
Decentralized clinical trials (DCTs) are revolutionizing the landscape of clinical research. As the FDA navigates this shift, the Decentralized...